Donepezil plus chromone plus melatonin hybrids as promising agents for Alzheimer's disease therapy Article

Pachon-Angona, Irene, Refouvelet, Bernard, Andrys, Rudolf et al. (2019). Donepezil plus chromone plus melatonin hybrids as promising agents for Alzheimer's disease therapy . 34(1), 479-489. 10.1080/14756366.2018.1545766

Open Access International Collaboration

cited authors

  • Pachon-Angona, Irene; Refouvelet, Bernard; Andrys, Rudolf; Martin, Helene; Luzet, Vincent; Iriepa, Isabel; Moraleda, Ignacio; Diez-Iriepa, Daniel; Oset-Gasque, Maria-Jesus; Marco-Contelles, Jose; Musilek, Kamil; Ismaili, Lhassane

sustainable development goals

authors

publication date

  • January 1, 2019

keywords

  • AMYLOID PEPTIDE
  • Antioxidant
  • BUTYRYLCHOLINESTERASE
  • Biochemistry & Molecular Biology
  • CHOLINESTERASE/MONOAMINE OXIDASE-INHIBITORS
  • Chemistry, Medicinal
  • Life Sciences & Biomedicine
  • MAO
  • MAO-A
  • MAO-B
  • MONOAMINE-OXIDASE
  • ORAC
  • PH
  • PHARMACOLOGICAL EVALUATION
  • POTENTIAL TREATMENT
  • Pharmacology & Pharmacy
  • Science & Technology
  • TARGET-DIRECTED LIGANDS
  • UPDATE
  • Ugi-4MCR
  • cholinesterases
  • donepezil

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 479

end page

  • 489

volume

  • 34

issue

  • 1